Gonorrhea Sexually Transmitted Disease Surveillance 2002

13
Gonorrhea Sexually Transmitted Disease Surveillance 2002 Division of STD Prevention

description

Gonorrhea Sexually Transmitted Disease Surveillance 2002. Division of STD Prevention. Gonorrhea — Rates: United States, 1970–2002 and the Healthy People 2010 objective. Note: The Healthy People 2010 objective for gonorrhea is 19.0 cases per 100,000 population. - PowerPoint PPT Presentation

Transcript of Gonorrhea Sexually Transmitted Disease Surveillance 2002

Page 1: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonorrhea

Sexually Transmitted Disease Surveillance 2002

Division of STD Prevention

Page 2: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonorrhea — Rates: United States, 1970–2002 and the Healthy People 2010 objective

Rate (per 100,000 population)

Gonorrhea2010 Objective

0

100

200

300

400

500

1970 73 76 79 82 85 88 91 94 97 2000

Note: The Healthy People 2010 objective for gonorrhea is 19.0 cases per 100,000 population.

Page 3: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonorrhea — Rates by state: United States and outlying areas, 2002

Rate per 100,000population

<=19.019.1-100.0>100.0

VT 16.1 NH 9.7 MA 51.1 RI 85.9 CT 95.2 NJ 93.8 DE 201.1 MD 176.6

Guam 31.7

Puerto Rico 10.8 Virgin Is. 45.1

(n= 9)(n= 20)(n= 24)

227.5

102.2

74.0171.5

72.6 81.6

133.6

224.6

61.1

7.3

193.5 121.6

50.6

102.1 93.3

254.8

11.1

148.6

62.0

241.7

160.0

13.6

91.4 99.5

80.4

115.1

192.9

11.2

193.8

135.1

26.6

108.2

228.1

34.8

164.3

129.4

16.7

147.8

49.6

53.9

118.2

13.2

Note: The total rate of gonorrhea for the United States and outlying areas (Guam, Puerto Rico and Virgin Islands) was 123.4 per 100,000 population. The Healthy People 2010 objective is 19.0 cases per 100,000 population.

Page 4: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonorrhea — Rates by county: United States, 2002

Note: The Healthy People 2010 objective for gonorrhea is 19.0 cases per 100,000 population.

Rate per 100,000population

<=19.019.1-100.0 (n=1033)

(n=730)

(n=1376)

>100.0

Page 5: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonorrhea — Rates by region: United States, 1981–2002 and the Healthy People 2010 objective

Rate (per 100,000 population)

WestMidwestNortheastSouth2010 Objective

0

120

240

360

480

600

1981 83 85 87 89 91 93 95 97 99 2001

Page 6: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonorrhea — Rates by sex: United States, 1981–2002 and the Healthy People 2010 objective

Rate (per 100,000 population)

MaleFemale2010 Objective

0

120

240

360

480

600

1981 83 85 87 89 91 93 95 97 99 2001

Page 7: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonorrhea — Rates by race and ethnicity: United States, 1981–2002 and the Healthy People 2010 objective

Rate (per 100,000 population)

WhiteBlackHispanicAsian/Pac IslAm Ind/AK Nat2010 Objective

0

500

1,000

1,500

2,000

2,500

1981 83 85 87 89 91 93 95 97 99 2001

Page 8: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonorrhea — Age- and sex-specific rates: United States, 2002

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-147.4

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

287.9

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

538.1

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

320.4

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

199.2

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

131.4

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

92.1

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

48.1

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

17.3

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

4.4

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

124.5

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14 46.6

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

675.6

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

650.3

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

251.4

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

113.1

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

57.4

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

31.3

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

10.6

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

2.1

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

0.8

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

Total 65+55-6445-5440-4435-3930-3425-2920-2415-1910-14

125.5

Page 9: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonorrhea — Positivity among 15-24 year old women tested in family planning clinics by state: United States and outlying areas,

2002

Positivity (%)

See *<1.01.0-1.9>=2.0

VT 0.2 NH 0.1 MA RI CT 0.8 NJ 1.3 DE MD DC 1.2

Puerto Rico 0.2 Virgin Is. 2.5

(n= 15)(n= 21)(n= 10)(n= 7)

2.3

0.6

1.5

0.9 0.5

0.6

2.4

0.1

1.8 1.2

0.7

0.7 0.7

2.4

1.0

2.8

0.9

0.6

0.6 1.2

0.7

1.5

0.7

0.9

1.4

0.7

1.0

0.2 2.8

2.7

0.4

*States reported gonorrhea positivity data on less than 500 women aged 15-24 years during 2002, except for Pennsylvania and Puerto Rico which submitted gonorrhea positivity data for April - December 2002 only.

SOURCE: Regional Infertility Prevention Projects; Office of Population Affairs; Local and State STD Control Programs; Centers for Disease Control and Prevention

Page 10: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonococcal Isolate Surveillance Project (GISP) — Location of participating clinics and regional laboratories: United States, 2002

Tripler AMC

Portland

San Francisco

Las Vegas

Long Beach

Orange Co.

San DiegoPhoenix

Anchorage

Honolulu

Albuquerque

Dallas

New Orleans

STD Clinics

BirminghamAtlanta

Ft. BraggGreensboro

BaltimoreCincinnati

St. Louis

ChicagoPhiladelphia

ClevelandMinneapolis

Denver

Miami

Seattle

Laboratories

Page 11: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonococcal Isolate Surveillance Project (GISP) — Penicillin and tetracycline resistance among GISP isolates, 2002

Note: PPNG=penicillinase-producing N. gonorrhoeae; TRNG=plasmid-mediated tetracycline resistant N. gonorrhoeae; PPNG-TRNG=plasmid-mediated penicillin and tetracycline resistant N. gonorrhoeae; PenR=chromosomally mediated penicillin resistant N. gonorrhoeae; TetR=chromosomally mediated tetracycline resistant N. gonorrhoeae; CMRNG=chromosomally mediated penicillin and tetracycline resistant N. gonorrhoeae.

Susceptible

PPNG

TRNG

PPNG/TRNG

PenR

TetR

CMRNG

82.0%

1.2%

4.3%

0.7%2.1%

5.5%

4.2%

Page 12: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate

resistance to ciprofloxacin, 1990–2002

Percent

Resistance

Intermediate resistance

0.0

0.8

1.6

2.4

3.2

4.0

1990 91 92 93 94 95 96 97 98 99 2000 01 02

Note: Resistant isolates have ciprofloxacin MICs > 1 g/ml. Isolates with intermediate resistance have ciprofloxacin MICs of 0.125 - 0.5 g/ml. Susceptibility to ciprofloxacin was first measured in GISP in 1990.

Page 13: Gonorrhea Sexually Transmitted Disease Surveillance 2002

Gonococcal Isolate Surveillance Project (GISP) — Percent of men with gonorrhea who had a previous gonorrhea infection, 1991–2002

Percent

Ever*Last 12 months**

0

12

24

36

48

60

1991 92 93 94 95 96 97 98 99 2000 01 02

*Data first collected in 1991.**Data first collected in 1992.